E-LIB Suche - Ergebnisse für: Han, Ji-Youn

1

Lazertinib as a frontline treatment in patients with EGFR-m..:

Chul Cho, Byoung ; Han, Ji-Youn ; Hyeong Lee, Ki...
Lung Cancer. 190 (2024) - p. 107509 , 2024

2

Efficacy and safety of tepotinib in Asian patients with adv..:

Kato, Terufumi ; Yang, James Chih-Hsin ; Ahn, Myung-Ju...
British Journal of Cancer. 130 (2024) 10 - p. 1679-1686 , 2024

Link: https://doi.org/10.1038/..

3

Avelumab in Combination With Lorlatinib or Crizotinib in Pa..:

Solomon, Benjamin J. ; Dagogo-Jack, Ibiayi ; Lee, Se-Hoon...
JTO Clinical and Research Reports. 5 (2024) 7 - p. 100685 , 2024

Link: https://doi.org/10.1016/..

4

TARGET: A Phase II, Open-Label, Single-Arm Study of 5-Year ..:

Soo, Ross Andrew ; de Marinis, Filippo ; Han, Ji-Youn...
Clinical Lung Cancer. 25 (2024) 1 - p. 80-84 , 2024

Link: https://doi.org/10.1016/..

5

Drug Response of Patient-Derived Lung Cancer Cells Predicts..:

Kim, Sunshin ; Lee, Youngjoo ; Song, Bo Ram...
Cancers. 16 (2024) 4 - p. 778 , 2024

Link: https://doi.org/10.3390/..

6

Tumor Microenvironment Modulation by Neoadjuvant Erlotinib ..:

Ahn, Beung-Chul ; Park, Charny ; Kim, Moon Soo...
Cancer Research and Treatment. 56 (2024) 1 - p. 70-80 , 2024

Link: https://doi.org/10.4143/..

7

Association Between Nutritional Status, Nutrient Intakes, a..:

Wie, Gyung Ah ; Kim, So Young ; Kim, Jiseon...
Current Developments in Nutrition. 8 (2024) - p. 102383 , 2024

Link: https://doi.org/10.1016/..

8

Molecular Subtypes and Tumor Microenvironment Characteristi..:

Kim, Jihyun ; Kim, Sunshin ; Park, Seog-Yun...
Cancers. 15 (2023) 14 - p. 3568 , 2023

Link: https://doi.org/10.3390/..

9

A Randomized Phase II Study of Irinotecan Plus Cisplatin wi..:

Lee, Youngjoo ; Lee, Soo-Hyun ; Lee, Geon Kook..
Cancer Research and Treatment. 55 (2023) 3 - p. 885-893 , 2023

Link: https://doi.org/10.4143/..

10

Tepotinib in patients with non-small cell lung cancer with ..:

Le, Xiuning ; Paz-Ares, Luis G. ; Van Meerbeeck, Jan...
Cell Reports Medicine. 4 (2023) 11 - p. 101280 , 2023

Link: https://doi.org/10.1016/..

11

Integrative analysis of risk factors for immune-related adv..:

Sung, Changhwan ; An, Jinhyeon ; Lee, Soohyeon...
Nature Cancer. 4 (2023) 6 - p. 844-859 , 2023

Link: https://doi.org/10.1038/..

12

Analysis of acquired resistance mechanisms to osimertinib i..:

Chmielecki, Juliann ; Mok, Tony ; Wu, Yi-Long...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

13

Splicing signature database development to delineate cancer..:

Lee, Kyubin ; Hyung, Daejin ; Cho, Soo Young...
Computational and Structural Biotechnology Journal. 21 (2023) - p. 1978-1988 , 2023

Link: https://doi.org/10.1016/..

14

Patient-derived cell-based pharmacogenomic assessment to un..:

Yu, Namhee ; Hwang, Mihwa ; Lee, Youngjoo...
Journal of Experimental & Clinical Cancer Research. 42 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

15

Single targeting of MET in EGFR-mutated and MET-amplified n..:

Choi, Yu-Ra ; Kang, Eun Hye ; Kim, Sunshin...
British Journal of Cancer. 128 (2023) 12 - p. 2186-2196 , 2023

Link: https://doi.org/10.1038/..